Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H1.5 is a member of the linker histone H1 family, which binds to DNA at the entry and exit sites on nucleosomes and stabilizes the structure of chromatin by promoting the compaction of chromatin fibers[2][3][4][6]. Unlike the core histones (H2A, H2B, H3, H4) that form the nucleosome core, linker histones like H1.5 do not make up the nucleosome "bead" but instead help organize and stabilize higher-order chromatin structures, influencing processes such as transcription, replication, and splicing[2][3][4]. H1.5 is particularly notable for its relatively long C-terminal domain, which is rich in positively charged residues and confers a higher affinity for chromatin, contributing to its longer residence time in chromatin compared to other H1 subtypes[1]. H1.5 has been shown to play a specific regulatory role in alternative mRNA splicing in differentiated cells by binding over splice sites, affecting exon inclusion and RNA polymerase II pausing at splice junctions[1]. The family of linker histones, including H1.5, mediates chromatin folding and modulates accessibility of DNA to transcription factors and other regulatory proteins, thereby exerting both structural and regulatory control over genetic information in eukaryotic cells[2][3][4][6]. At present, Histone H1.5 is not considered a direct therapeutic target or established biomarker, nor are there known drugs that selectively target it. Altered expression of H1.5 and other H1 variants has been observed in various cancers and during cell differentiation, suggesting possible disease associations but not direct druggability[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H1.5 (H1.5).